ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Enanta Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Enanta Pharmaceuticals, INC. (Enanta Pharmaceuticals, INC. 401(k) Profit Sharing Plan & Trust · EIN 04-3205099 · PN 001): $50.19M net assets, 132 active participants, and $2.98 per $10,000 (2.98 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorEnanta Pharmaceuticals, INC.
Filing IdentifierEnanta Pharmaceuticals, INC. 401(k) Profit Sharing Plan & Trust · EIN 04-3205099 · PN 001
Plan Category & State401(k) Defined Contribution (MA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$50.19M
Active Participants132
Direct Admin Fee Rate$2.98 per $10,000 (2.98 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI